Amarantus BioScience Holdings, Inc. (AMBS)

Market Cap	630.00 -99.9%
Revenue (ttm)	n/a
Net Income	-7.94M
EPS	-0.03
Shares Out	630.41M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.0001
Previous Close	0.0001
Day's Range	0.0001 - 0.0001
52-Week Range	n/a
Beta	-37.82
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About AMBS

Amarantus BioScience Holdings, Inc., a biopharmaceutical company, focuses on the development of diagnostic and therapeutic product candidates in the areas of neurology, psychiatry, ophthalmology, and regenerative medicine. The company’s diagnostic products in development include the lymphocyte proliferation (LymPro) test, a diagnostic blood test for Alzheimer’s disease; and MSPrecise, a proprietary DNA sequencing assay for the identification of patients with multiple sclerosis. Its therapeutic products in development comprise Eltoprazine, a sma...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2008
• Employees: 12
• Stock Exchange: OTCMKTS
• Ticker Symbol: AMBS

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Jun 24, 2026

Data Sources Report a data error